3.227 STUDY OF GLYCOSAMINOGLYCANS IN PARKINSON'S DISEASE AND THEIR IMPLICATIONS IN GDNF INDUCED PLASTICITY IN VITRO
Mohand Ouidir Ouidja(Centre National de la Recherche Scientifique), Dulce Papy-García(Université Paris-Est Créteil), Étienne C. Hirsch(Sorbonne Université), Christophe Morin(Centre National de la Recherche Scientifique), G. Zhang, Rita Raisman‐Vozari(Centre National de la Recherche Scientifique), Sonia Lehri-Boufala(Centre National de la Recherche Scientifique), Minh Bao Huynh(Centre National de la Recherche Scientifique)
Cited by 0
Related Papers
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
|Proceedings of the National Academy of Sciences|2013|864
FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces,<i>In Vitro,</i>Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial Cells
|Journal of Neuroscience|1999|359
Heparan Sulfate Is a Cellular Receptor for Purified Infectious Prions
|Journal of Biological Chemistry|2005|175
Novel tactics for neuroprotection in Parkinson's disease: Role of antibiotics, polyphenols and neuropeptides
|Progress in Neurobiology|2015|163